Month: April 2024

Paris, 10 April 2024, 6:00 p.m. PRESS RELEASE Availability of the 2023 Universal Registration Document including the integrated report Eramet announces the filing of its 2023 Universal Registration Document (“URD”) with the French Financial Markets Authority (Autorité des Marchés Financiers, “AMF”) today. The document was submitted in European Single Electronic Format (“ESEF”), as established by Delegated Regulation (EU) 2019/815. The URD is available on the AMF’s website as well as on the Company’s website (www.eramet.com, in the Investors / Regulated Information section). Copies of this document are also available, free of charge, at the Company’s registered office located at: 10, boulevard de Grenelle, 75015 Paris, France. The 2023 URD includes the following documents:2023 annual financial report, including the Statement on...

OSE Immunotherapeutics Receives €8.4 M in Public Funding to Support the Registration Phase 3 Clinical Trial of Cancer Vaccine Tedopi® in Lung CancerNantes, France – April 10, 2024 – 6:00 pm CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announced the Company has received €8.4 million in non-dilutive funding under the “i-Démo” call for projects as part of the plan “France 2030” operated by Bpifrance on behalf of the State. This plan aims at developing industrial companies in growth markets that create value and competitiveness for the French economy and also contribute to energy, ecological and digital transitions. This financial support applies from the feasibility study to marketing. This public funding will support the registration Phase 3 clinical trial of neoepitope-based cancer vaccine Tedopi®, in second...

ORMOND BEACH, Fla. and GERMANTOWN, Md., April 10, 2024 (GLOBE NEWSWIRE) — Germfree, a leading innovator in modular cleanroom infrastructure and services, and Orgenesis Inc. (Nasdaq: ORGS), a global leader in decentralizing cell and gene therapies (CGTs), today announced an asset purchase and strategic partnership aimed at advancing Orgenesis’ therapeutic programs and its suite of product development and GMP cell processing services. The collaboration’s goal is to transform the production of cell and gene therapies, making these vital treatments more affordable and accessible to patients worldwide. By combining Germfree’s expertise in designing, manufacturing, and maintaining advanced manufacturing facility environments with Orgenesis’ cutting-edge processes and analytical development capabilities, the partnership seeks to significantly...

Pre-clinical findings underscore the potential of APR-1051, a next-generation WEE1 kinase inhibitor, to be a well-tolerated and effective treatment for Cyclin E-overexpressing cancers IND for APR-1051 has been cleared; details on planned Phase 1 first in human trial (ACESOT-1051) presented ATRN-119, a novel macrocyclic ATR inhibitor, continues to appear safe and well tolerated with no Dose Limiting Toxicities observed in ongoing Phase 1/2a study; preliminary signs of clinical benefit reported; enrollment in the study continues DOYLESTOWN, Pa., April 10, 2024 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality, today released details about four poster presentations at the ongoing American Association...

SPRING CITY, Pa., April 10, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest community, Riverstone Crossing, is coming soon to East Vincent Township in Chester County, Pennsylvania. Construction of the Toll Brothers Sales Center and model homes, located at 202 Polaris Drive in Spring City, Pennsylvania, is set to begin in the summer of 2024 and sales will start this fall. Located just minutes from Phoenixville and Collegeville, Riverstone Crossing will include 33 Toll Brothers single-family homes in a private location with a beautiful tree-lined backdrop. Home buyers will be able to choose from three exquisite home designs ranging from 2,583 to over 3,029 square feet of luxury living space, each built with the outstanding quality, craftsmanship, and...

Grenoble, April 10, 2024 – 6:00 pm CEST – The Board of Directors of McPhy Energy (the “Company”), meeting on April 9, 2024, decided to submit to the next Combined Shareholders’ Meeting, to be held on May 30, 2024, in its ordinary part, for approval the proposed transfer of the Company’s shares listing from the regulated market of Euronext Paris (compartment C) to the organized multilateral trading facility of Euronext Growth Paris. Reasons for the proposed transfer This proposed transfer would enable the Company to have its shares admitted to trading on a growth market for SMEs, in line with its current size and share profile, and would alleviate the obligations and constraints with which it has currently to comply. This would enable the Company to simplify and reduce the resources mobilized for its listing, while benefiting...

Newly Branded Global Channel with 300,000+ Subscribers Pays Tribute to Stan Lee, Offering Exclusive Content from and Inspired by the “Godfather of Comics” “Stan Lee Presents” Channel Curated by Stan’s Longtime Collaborators, Including Originator and Executive Producer of the Batman Movie Franchise, Michael Uslan BEVERLY HILLS, Calif., April 10, 2024 (GLOBE NEWSWIRE) — Paying tribute to the legacy of the “godfather of comics” and the chief architect of the Marvel Universe, Kartoon Studios (NYSE AMERICAN:TOON), the controlling partner of “Stan Lee Universe, LLC,” announced today the launch of the “Stan Lee Presents” channel on YouTube, with over 300,000 subscribers. The newly branded channel, formerly “Cinematica,” will be managed by Kartoon Studios’ subsidiary Frederator Networks, one of the largest animation networks on YouTube, with...

Featuring Compact 3.8 mm by 2.0 mm Footprint, Low 0.88 mm Profile, and Wettable Flanks, Space-Saving Devices Offer Operating Temperatures to +185 °C MALVERN, Pa., April 10, 2024 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc. (NYSE: VSH) today introduced four new series of surface-mount industrial-grade TRANSZORB® and Automotive Grade PAR® transient voltage suppressors (TVS) in the low profile DFN3820A package with wettable flanks. Providing space-saving solutions for automotive, computer, consumer, and industrial applications, the 6DFNxxA, 6DFNxxxCA, T6NxxA, and T6NxxxCA offer peak pulse power of 600 W at 10/1000 μs and low leakage current down to 1 μA. The first package in Vishay’s new Power DFN family, the DFN3820A features a compact 3.8 mm by 2.0 mm footprint and an extremely low typical height of 0.88 mm, allowing the Vishay...